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Abstract 
 
Background:  Endometrial cancer also referred to as uterine corpus cancer is the fourth most 
common cancer diagnosed among US women. It is also one of the few cancers in the US that has 
an increasing incidence and mortality rate. This study examined the overall and race specific 
age-adjusted incidence rate as well as incidence-based mortality rate of endometrial cancer in the 
United States from 1975-2016.  
Methods: Surveillance, Epidemiology, and End Results (SEER) 1975-2016 data were used. 
Overall and race specific age-adjusted incidence rate, incidence-based mortality rates and 95% 
confidence intervals were calculated Trend graphs were created, annual average percent change 
and annual percent change were calculated using joinpoint regression analysis. All analyses were 
conducted using SEER*Stat Software.  
Results:  The overall age-adjusted incidence rate of endometrial cancer from 1975-2016 was 
estimated to 20.7 (95% CI 20.6-20.8) per 100,000 and the age-adjusted incidence-based 
mortality rate was 11.9 (95% CI 11.8-12) per 100,000. Among white women, the annual average 
percent change in the incidence-based mortality rate of endometrial cancer from 1975 through 
2016 showed an overall increase of 5.4%. From 1993 till 2016 the incidence rates among African 
American women had increased by 2.1% per year.  
Conclusion: Endometrial cancer burden is increasing especially among African American 
women. Developing control and prevention methods coupled with better access to appropriate 
care can help in reducing endometrial cancer disparity and burden.   
Keywords: Endometrial Cancer, Corpus Uteri Cancer, Incidence, Incidence-Based Mortality, and 
Racial Disparity. 
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Background 
Endometrial cancer also referred to as uterine corpus cancer is the fourth most common cancer 
diagnosed among US women (Henley, Miller, Dowling, Benard & Richardson, 2018). It is also 
the most common cancer of the female reproductive organs and the seventh most common cause 
of cancer mortality in the US (American Cancer Society, 2019a; Henley, Miller, Dowling, 
Benard & Richardson, 2018).  
Endometrial cancer develops in the endometrium layer of the uterus (American Cancer Society, 
2019b). Common signs and symptoms of endometrial cancer are pelvic pain or pressure, vaginal 
bleeding after menopause, weight loss, abnormal vaginal discharge and bleeding between 
periods (Mayo Clinic, 2019). Obesity and insufficient physical activity are the most common risk 
factor as an estimated 70% of uterine corpus cancers are attributed to them (American Cancer 
Society, 2019c). The risk of endometrial cancer also increases with age (Centers for Disease 
Control and Prevention (CDC), 2019a). Other risk factors include an increased amount of 
estrogen in the body, never having been pregnant, ovarian diseases such as polycystic ovarian 
syndrome (PCOS), late menopause and family history (Mayo Clinic, 2019). There is no specific 
screening test for endometrial cancer but some of the commonly used diagnostic methods are an 
endometrial biopsy, Dilation and Curettage (D&C), and hysteroscopy (MD Anderson Cancer 
Center, 2019).  
In the United States, 56,808 new cases of endometrial cancer were reported in 2016 with an 
incidence rate of 27 cases per 100,000 women. In the same year, 10,733 women died because of 
endometrial cancer (CDC, 2019b). In 2019, an estimated 61,880 cases of endometrial cancer will 
be diagnosed in the United States and about 12,160 deaths will occur due to endometrial cancer 
(American Cancer Society, 2019a). Studies also suggest that endometrial cancer is one of the few 
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cancers in the United States that has an increasing incidence and mortality and the numbers are 
predicted to continue to increase (Cote, Ruterbusch, Olson, Lu, & Ali-Fehmi, 2015; Henley, 
Miller, Dowling, Benard & Richardson, 2018). Along with the increasing incidence of 
endometrial cancer, some studies have reported racial disparities in mortality rates of 
endometrial cancer in the recent years (Doll, Winn, & Goff, 2017; Long, Liu, & Bristow, 2013; 
Rauh-Hain et al., 2015).  
Previous studies that examined the endometrial cancer incidence rates and incidence-based 
mortality rates only used data generated mainly for the last two decades (Cote, Ruterbusch, 
Olson, & Ali-Fehmi, 2015; Henley, Miller, Dowling, Benard, & Richardson, 2018; Long, Liu, & 
Bristow, 2013). There was a research gap in reporting of incidence and mortality rate trends of 
data available for all years i.e. from 1975-2016. No study has comprehensively analyzed the 
incidence and mortality data along with providing information about significant time trend 
changes and annual percent change.  
Since endometrial cancer is relatively uncommon, by estimating the time trends from 1975-2016, 
a better understanding of the incidence and mortality rates can be developed. Estimation of the 
time periods where significant changes occur could help in identifying factors that might be 
associated with an increased incidence or mortality rate. These factors could potentially be 
studied to provide better future recommendations to reduce the burden of endometrial cancer. 
Therefore, this study aimed to examine the overall and race specific age-adjusted incidence rate 
and incidence-based mortality of endometrial cancer in the United States from 1975-2016.  
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The aims and hypothesis of this study were: 
Aim 1: Examine overall and race specific age-adjusted incidence rates of endometrial cancer in 
the United States during the period 1975-2016 
Hypothesis: The age-adjusted incidence rate of endometrial cancer is significantly higher among 
African American women than among white women. 
Aim 2: Examine overall and race specific age-adjusted incidence-based mortality rate of 
endometrial cancer in the United States.  
Hypothesis: The age-adjusted incidence-based mortality rate of endometrial cancer is 
significantly higher among African American women than among white women. 
Methods 
Study Design:  
This was a secondary data analysis study using the 1975-2016 Surveillance, Epidemiology, End 
Results (SEER) database.  
SEER Program:  
The Surveillance, Epidemiology, and End Results (SEER) is a population-based program of the 
National Cancer Institute (National Cancer Institute, 2019a). SEER began collecting data in 1973 
in the states of Connecticut, Iowa, New Mexico, Utah, and Hawaii and the metropolitan areas of 
Detroit and San Francisco-Oakland (National Cancer Institute, 2019b). Since then the SEER 
Program has been expanded and it now covers 21 population-based registries (Figure 1) and 
covers approximately 34.6% of the U.S. population. The SEER Program registries collect data 
on patient demographics, tumor site, tumor morphology, stage at diagnosis, first course of 
treatment, and follow-up for vital status.  
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Figure 1. SEER Cancer Registries  
 
Study Dataset: 
There are four combinations of SEER registries available (SEER 9, SEER 13, SEER 18, SEER 
21). For our analysis, we used the SEER 9 dataset that covers the longest period of time (1975-
2016) among all 4 groupings. The SEER 9 dataset covers the following geographic areas: 
Atlanta (Metropolitan), Connecticut, Detroit (Metropolitan), Hawaii, Iowa, New Mexico, San 
Francisco-Oakland SMSA(Standard Metropolitan Statistical Area), Seattle (Puget Sound), and 
Utah (National Cancer Institute, 2019c).  
We used the “Incidence - SEER 9 Regs Research Data, Nov 2018 Sub (1975-2016) 
<Katrina/Rita Population Adjustment>” dataset for Aim 1 and “Incidence-Based Mortality - 
SEER 9 Regs Research Data, Nov 2018 Sub (1975-2016) <Katrina/Rita Population 
Adjustment>” dataset for Aim 2. SEER 9 dataset covers approximately 9.4% of the U.S. 
population and rates are available for white, African American, other (American Indian/Alaskan 
Native (AI/AN), Asian or Pacific Islander (API)) races. It also has two age variables: 19 age 
groups (< 1 year, 1-4 years, 5-9 years, ..., 85+ years) and single ages with 85+ (National Cancer 
Institute, 2019d).  
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Study Population:  
As endometrial cancer primarily affects adult women, our study only included women who were 
older than 19 years at the time of endometrial cancer diagnosis. Incidence and mortality rates 
were calculated among women for all endometrial cancer stages and grades. The ICD-O-3 site 
codes examined were Corpus Uteri C540-C549 and Uterus, NOS C559.  
Statistical Software Used: 
We used the SEER*Stat software (Version 8.3.6) to examine age-adjusted rates and incidence 
mortality rates. We used Joinpoint Regression Program (Version 4.7.0.0) to examine the time 
trends.  
Statistical Analysis:  
The age adjustment was done according to the 2000 US census data (2000 Standard US 
population). An age-adjusted rate is a weighted average of the crude rates, where the weights are 
the proportions of persons in the corresponding age groups of a standard population (National 
Cancer Institute, 2019e).  By age-adjusting, the potential confounding effect of age was reduced 
as the rates were calculated using the same standard population. The existing age variable in the 
SEER*Stat software was used to create a user-defined age group that had women older than 19 
years. The required ICD-O-3 site codes (Corpus Uteri C540-C549 and Uterus, NOS C559) were 
defined and the analysis was performed. The overall and race specific incidence and mortality 
rate along with confidence intervals were obtained for each year. The age-adjusted incidence 
rates were calculated by first identifying the number of cases of endometrial cancer (ICD-O-3 
Site codes defined above) for each age group above 19 years in the SEER 9 registries from 1975-
2016. Crude rates were calculated for each age group using the population data. Proportions 
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based on the standard population (2000 US population) were estimated for each age group and 
were used as weights. The age adjusted rate was obtained by multiplying each crude rate by the 
appropriate weight and summing the products. Same procedure was followed when calculating 
incidence-based mortality rate (dataset for mortality rate was used). Incidence-based mortality is 
different from mortality rate as it allows a partitioning of mortality by variables associated with 
the cancer onset (National Cancer Institute, 2019f; Saad, Turk, Al-Husseini, & Abdel-Rahman, 
2018). Mortality data collected from death certificate has a limitation as it does not provide 
information about the onset of disease, stage at diagnosis or the disease histology. SEER collect 
these types of data and allow the calculation of an incidence-file based mortality rate. It however 
does not change the overall mortality rate.   
 These tables were then retrieved as ASCII text files. A total of four ASCII files were extracted. 
Two files contained data about overall and race based age-adjusted incidence rates and the other 
two had overall and race based mortality data.  
These files were then used as input files for performing joinpoint analysis using the Joinpoint 
Regression Program (Version 4.7.0.0). The ASCII files were then analyzed in Joinpoint software 
one by one. For each model, a minimum of zero joinpoint (produces one-line segment) and a 
maximum of five joinpoints (produces six-line segments) were allowed. Overall incidence and 
mortality trend graphs were obtained from 1975-2016. Joinpoint regression is a weighted least-
squares regression method that fits linear segments to log-transformed rates (Jamison, Noone, 
Ries, Lee, & Edwards, 2013). Line segments are joined at points called joinpoints. Each 
joinpoint denotes a statistically significant (P = .05) change in trend. Joinpoint analysis created 
separate trend graphs for each race. The average annual percent change and year trends with a 
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significant change in incidence and mortality rates were calculated. The annual percent change 
was also measured for each significant time trend. 
Results 
Age-Adjusted Incidence Rate:  
The age-adjusted incidence rate for endometrial cancer among US adult women for the period 
1975-2016 was 20.7 per 100,000 with an estimated 95% confidence interval of 20.6-20.8. The 
latest age-adjusted incidence rate in 2016 was 20.8 (20.2-21.4) per 100,000. Table 1 shows the 
annual age-adjusted incidence rate of endometrial cancer from 1975-2016. The highest incidence 
rate reported was 29.5 (95% CI 28.6-30.5) per 100,000 in 1975 and the lowest incidence rate was 
observed in 2003 and 2006 at 18.7 (95% CI 18.1-19.3) per 100,000.  
For the period 1975-2016, the overall age-adjusted incidence rate of endometrial cancer varied 
by race – it was highest among whites at 21.4 per 100,000, followed by women in the other race 
category at 15.8 per 100,000, and lowest among African Americans at 17.5 per 100,000. There 
were statistically significant differences in the overall age-adjusted incidence rates during the 
period 1975-2016 among these three groups. However, in 2016, the age-adjusted incidence rate 
among African American women was 22.4 (95% CI 20.6-24.4) per 100,000, significantly higher 
than the age-adjusted incidence rate among white at 20.5 (95% CI 19.9-21.5) per 100,000.  
The overall and race based AAPC and APC of age-adjusted incidence rates (1975-2016) are 
reported in Table 3 and Figures 2-4. The Joinpoint analysis results indicate that the overall 
average annual percent change (AAPC) in the incidence rate of endometrial cancer from 1975 
through 2016 was -0.9 percent. The largest decline was observed from 1975 through 1979 when 
the incidence rate decreased by 6.6 per year. The overall rates have remained stable from 2009 to 
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2016 with a 0.0% annual percent change (APC). Among white women, the annual average 
percent change in the incidence rate of endometrial cancer from 1975 through 2016 was -1.1%. 
From 1974 till 1979 the incidence rate decreased by 6.7% per year and from 1979 to 1988 the 
annual percent change was -1.7%. In recent years (2010-2016) the rates have been decreasing by 
0.2% per year. For African American women, the annual average percent change of incidence 
rate from 1975-2016 was +1% per year. Between 1975 and 1993 the incidence rate decreased by 
0.5% per year but from 1993 till 2016 the rates had increased by 2.1% per year.  
Age-Adjusted Incidence-Based Mortality Rate: 
The annual age-adjusted incidence-based mortality rates from 1975 through 2016 are 
summarized in Table 4. The overall age-adjusted incidence-based mortality rate of endometrial 
cancer for the years 1975-2016 was 11.9 (95% CI 11.8-12) per 100,000. The highest incidence-
based mortality rate was 14.5 (95% CI 13.9-15) per 100,000, which was noted in the year 2002, 
whereas, the lowest incidence rate was reported as 11.7 (95% CI 1.4-1.9) per 100,000 in 1975. 
The age-adjusted incidence-based mortality rate observed for the most recent year (2016) was 
13.2 (95% CI 12.8-13.7) per 100,000.  
As shown in Table 5, among white women the overall age-adjusted incidence-based mortality 
rate of endometrial cancer from 1975-2016 was 12.3 (95% CI 12.2-12.4) per 100,000, which was 
almost similar to the overall incidence-based mortality rate observed in African American 
women at 12 (95% CI 11.7-12.3) per 100,000 The highest and lowest incidence-based mortality 
rate reported for white women was 15.1 (95% CI 14.5-15.7) per 100,000 in 2002 and 2005 and 
1.6 (95% CI 1.4-1.9) in 1975 respectively. For African American women, the highest incidence-
based mortality rate was observed in 2011 which was 14.9 (95% CI 13.1-16.8) per 100,000 and 
the lowest incidence-based mortality rate was 2.5 (95% CI 1.4-4) in 1975. In 2016, the 
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incidence-based mortality rate among African American women was 14.7 (95% CI 13.1-16.5) 
per 100,000 which was higher as compared to white women whose incidence-based mortality 
was estimated to be 13.7 (95% CI 13.1-14.2) per 100,000.  
Overall average annual percent change in the incidence-based mortality rate of endometrial 
cancer from 1975 through 2016 was +5.1% (Table 6). From 1975-1977 the most significant 
change was observed where the incidence-based mortality rates increased by 58.9% per year. An 
annual increase in rates was also reported from 1977-2001. The rates declined by only 0.4% per 
year from 2001-2016. Among white women, the annual average percent change in the incidence-
based mortality rate of endometrial cancer from 1975 through 2016 is 5.4%. The most significant 
increase was observed through 1975-1979 wherein the rates increased by 63.5 % per year. An 
annual decline in rates is noted from 2001-2005 with a 0.4% decrease per year. The average 
annual percent change in the incidence-based mortality rate of endometrial cancer amid African 
American women from 1975 till 2016 is 2.8%. The rates increased by 12.4% per year starting 
from 1975 through 1981. The rates still consistently increased from 1981 to 2016 by 1.3% per 
year.   
Discussion 
Summary and Major Findings: 
This study reports the age-adjusted incidence and incidence-based mortality rates data for the 
most available years (1975-2016) in the United States. Overall and race specific incidence and 
mortality rates were estimated. The overall age-adjusted incidence rate of endometrial cancer 
from 1975-2016 was calculated to be 20.7 (95% CI 20.6-20.8) per 100,000. A declining trend in 
the overall incidence rate was noted from 1975-1988. These rates then increased by 3,2% per 
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year from 2006-2009 which was similar to the increased incidence rate reported by Cote et al., 
2015. The rates were found to be consistent from 2009-2016 with no an annual percent change.  
This study highlights the importance of examining the time trends for specific population groups. 
While the age-adjusted incidence rate for the combined years from 1975-2016 was significantly 
higher among white women at 21.4 per 100,000 as compared to an incidence rate of 17.5 among 
African American women, in 2016, the incidence rate among African American women was 22.4 
(95% CI 20.6-24.4) per 100,000 and 20.5 (95% CI 19.9-21.5) per 100,000 among white women. 
Incidence rates were higher among white and African American women as compared to other 
race groups for 2016. Our results were comparable with the findings of Henley et al., 2018 who 
also described a higher incidence rate among African American and white women as compared 
to other racial groups in 2015.  
We observed different time trends of endometrial incidence rates between whites and African 
American women. From 2010-2016, the rates had been decreasing by 0.2% per year among 
white women whereas they had been increasing by 2.1% per year amid African American 
women. Even the average annual percent change from 1975-2016 was higher for African 
American women. One of the potential contributing factors for this difference could be the 
higher and consistently increasing obesity rates among African American women as compared to 
white women (American Cancer Society, 2019c; Block, Rawat, Brosgart, & Francisco, 2017). 
The overall age-adjusted incidence-based mortality rate of endometrial cancer for the years 
1975-2016 was 11.9 (95% CI 11.8-12) per 100,000 and the average annual percent change is 
5.1%, which indicates an overall increasing trend of endometrial cancer mortality. In 2016, the 
mortality rate among African American women was 14.7 (95% CI 13.1-16.5) which was higher 
than the observed mortality rate of 13.7 (95% CI 13.1-14.2) among white women and our study 
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finding was also similar to other studies like Henley et al.,(2018) who have also reported higher 
mortality rate among African American women in 2016. These results align with our study 
hypothesis of higher mortality rate among African American women compared to white women 
for 2016. Significant annual percent change in the incidence-based mortality rate was observed 
between 1975-1977 where the overall rate increased by 58.9% per year and by 63.5% per year 
among white women but between 2001-2016 the rates have decreased by 0.4% per year. The 
mortality trends data also suggests that the mortality rate had been increasing by 1.3% per year 
among African American women. These increasing rates could be associated with late stage 
diagnosis of endometrial cancer among African American women as compared to early diagnosis 
amid white women. This association was also reported in studies by Baskovic et al., (2018) and 
Rauh-Hain et al., (2015).  
Strengths and Limitations 
Our study utilized a dataset that has endometrial incidence and mortality data for the most 
available years. Therefore, our results are comprehensive. Also, it was the first study to estimate 
the AAPC and APC of endometrial cancer incidence and incidence-based mortality rate from 
1975-2016. This study also has some potential limitations. One of the main limitations is that 
since (SEER) cancer registries collect limited information on sociodemographic information and 
potential risk factors, it was not possible to identify reasons for changes in the trends. Other 
study limitation is that the findings of our study cannot be generalized to women living outside 
of SEER 9 program areas.  
This study highlights the burden of endometrial cancer especially among African American 
women. Steps should be taken to develop effective interventions strategies which allow early 
detection of endometrial cancer among African American Women. Future studies could 
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investigate factors associated with changes in incidence and mortality trends. By designing 
control and prevention measures and increasing awareness among women about endometrial 
cancers’ risk factors and the importance of seeking timely healthcare would help in reducing 
endometrial cancer disparities and overall disease burden.  
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Tables and Figures 
Table 1: Overall age-adjusted incidence rates of endometrial cancer in adult (Age >19 Years) 
women from 1975-2016. 
Year Rate (per 100,000) Lower CI Upper CI 
1975 29.5 28.6 30.5 
1976 28.5 27.5 29.4 
1977 25.8 25.0 26.7 
1978 24.8 23.9 25.7 
1979 22.6 21.8 23.4 
1980 22.2 21.4 23.1 
1981 22.0 21.2 22.8 
1982 21.6 20.9 22.4 
1983 21.4 20.6 22.2 
1984 20.8 20.1 21.6 
1985 20.5 19.8 21.3 
1986 19.7 19.0 20.4 
1987 19.9 19.2 20.7 
1988 19.0 18.3 19.7 
1989 19.6 18.8 20.3 
1990 20.1 19.4 20.8 
1991 19.7 19.0 20.4 
1992 19.8 19.1 20.5 
1993 19.5 18.8 20.2 
1994 19.9 19.3 20.6 
1995 19.9 19.2 20.6 
1996 19.7 19.1 20.4 
1997 20.3 19.6 20.9 
1998 20.1 19.4 20.7 
1999 19.8 19.1 20.4 
2000 19.2 18.6 19.9 
2001 19.6 18.9 20.2 
2002 19.2 18.5 19.8 
2003 18.7 18.1 19.3 
2004 19.2 18.6 19.8 
2005 19.0 18.4 19.6 
2006 18.7 18.1 19.3 
2007 19.2 18.6 19.8 
2008 19.7 19.1 20.3 
2009 20.7 20.1 21.3 
2010 20.7 20.1 21.3 
2011 20.4 19.8 21.0 
2012 20.6 20.0 21.2 
2013 20.2 19.6 20.8 
2014 20.6 20.0 21.2 
2015 20.5 20.0 21.1 
2016 20.8 20.2 21.4 
1975-2016 20.7 20.6 20.8 
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Table 2: Race based age-adjusted incidence rates of endometrial cancer in adult (Age >19 
Years) women from 1975-2016 
*Other includes American Indian/AK Native, Asian/Pacific Islander 
 
Year White African American Others* 
 Rate LCI UCI Rate LCI UCI Rate LCI UCI 
1975 31.1 30.1 32.2 16.6 13.7 19.9 17.3 14.2 20.9 
1976 30.1 29.1 31.1 14.7 12.0 17.9 17.9 14.5 21.7 
1977 27.1 26.1 28.1 16.9 14.1 20.1 16.3 13.3 19.7 
1978 26.2 25.2 27.1 15.7 13.1 18.7 11.6 9.2 14.4 
1979 23.6 22.7 24.5 14.4 11.9 17.2 14.6 11.8 17.7 
1980 23.3 22.4 24.2 13.5 11.2 16.2 15.2 12.5 18.4 
1981 22.9 22.1 23.8 14.4 11.9 17.2 15.5 12.8 18.5 
1982 22.8 21.9 23.7 14.1 11.7 16.8 13.8 11.3 16.7 
1983 22.4 21.6 23.3 15.5 13.1 18.3 13.3 10.9 16.1 
1984 21.9 21.1 22.8 14.5 12.1 17.1 11.5 9.3 13.9 
1985 21.5 20.7 22.4 14.9 12.6 17.5 12.3 10.1 14.8 
1986 20.7 19.9 21.5 13.9 11.7 16.3 13.2 10.9 15.7 
1987 21.1 20.3 21.9 13.2 11.1 15.5 12.5 10.4 14.9 
1988 19.8 19.1 20.6 13.9 11.8 16.3 13.5 11.4 16.0 
1989 20.4 19.6 21.2 16.2 13.9 18.8 13.2 11.1 15.6 
1990 21.2 20.4 22.0 14.2 12.1 16.6 12.1 10.1 14.3 
1991 20.8 20.0 21.6 14.4 12.3 16.8 12.9 10.9 15.2 
1992 20.8 20.0 21.6 14.4 12.3 16.7 13.2 11.2 15.3 
1993 20.5 19.8 21.3 14.3 12.3 16.6 12.9 11.0 15.0 
1994 20.9 20.1 21.6 14.6 12.6 16.9 14.1 12.2 16.2 
1995 20.8 20.0 21.6 15.4 13.3 17.6 14.5 12.6 16.5 
1996 20.5 19.8 21.3 16.3 14.2 18.6 14.7 12.8 16.8 
1997 21.3 20.5 22.0 14.0 12.0 16.1 15.2 13.3 17.2 
1998 20.9 20.2 21.7 16.1 14.1 18.4 14.6 12.8 16.6 
1999 20.7 20.0 21.5 14.8 12.8 16.9 15.0 13.2 16.9 
2000 20.2 19.5 20.9 15.1 13.1 17.2 13.9 12.2 15.7 
2001 20.5 19.8 21.2 16.0 14.0 18.2 14.0 12.4 15.8 
2002 19.3 18.6 20.0 19.0 16.9 21.2 16.9 15.1 18.8 
2003 19.5 18.8 20.2 16.6 14.6 18.7 13.5 11.9 15.2 
2004 19.7 19.1 20.5 16.9 15.0 19.0 15.8 14.2 17.6 
2005 19.4 18.7 20.1 19.5 17.4 21.8 15.5 13.9 17.2 
2006 19.6 18.9 20.3 15.7 13.9 17.7 13.5 12.1 15.1 
2007 19.6 18.9 20.3 18.5 16.5 20.6 16.3 14.7 18.0 
2008 19.9 19.3 20.6 19.7 17.8 21.8 17.1 15.6 18.9 
2009 20.9 20.2 21.6 20.6 18.6 22.7 17.8 16.2 19.5 
2010 20.9 20.2 21.6 20.2 18.2 22.3 18.8 17.2 20.5 
2011 20.3 19.6 21.0 22.9 20.9 25.1 18.2 16.6 19.9 
2012 20.8 20.2 21.5 20.3 18.5 22.3 17.5 16.0 19.1 
2013 20.0 19.3 20.6 22.4 20.5 24.5 19.0 17.5 20.7 
2014 20.9 20.3 21.6 20.8 19.0 22.8 17.0 15.5 18.5 
2015 20.4 19.7 21.1 22.3 20.4 24.2 18.4 17.0 20.0 
2016 20.5 19.9 21.2 22.4 20.6 24.4 19.0 17.5 20.5 
1975-2016 21.4 21.3 21.5 17.5 17.1 17.8 15.8 15.5 16.1 
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Table 3: Overall and race based annual age-adjusted incidence rate trends (Joinpoint Analysis 
for 1975-2016)  
 
 
Overall/Race 
 
 
AAPC** 
Joinpoint Analysis (1975-2016) 
Trend 1 Trend 2 Trend 3 Trend 4 Trend 5 Trend 6 
Years APC* Years APC* Years APC* Years APC* Years APC* Years APC* 
Overall -0.9 1975-
1979 
-6.6 1979-
1988 
-1.8 1988-
1997 
0.4 1997-
2006 
-0.8 2006-
2009 
3.2 2009-
2016 
0.0 
White -1.1 1975-
1979 
-6.7 1979-
1988 
-1.7 1988-
1997 
0.3 1997-
2005 
-1.1 2005-
2010 
1.4 2010-
2016 
-0.2 
African 
American 
1.0 1975-
1993 
-0.5 1993-
2016 
2.1         
**AAPC is the Average Annual Percent Change                                                                    *APC is the Annual Percent Change 
 
Figure 2: Overall age-adjusted incidence rate trend of endometrial cancer (Joinpoint Analysis 
for 1975-2016)  
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Figure 3: Age-adjusted incidence rate trend of endometrial cancer among adult white women 
(Joinpoint Analysis for 1975-2016)  
 
Figure 4: Age-adjusted incidence rate trend of endometrial cancer among adult African 
American women (Joinpoint Analysis for 1975-2016) 
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Table 4: Overall age-adjusted incidence-based mortality rates of endometrial cancer in adult 
(Age >19 Years) women from 1975-2016 
 
Year Rate (per 100,000) Lower CI Upper CI 
1975 1.7 1.4 1.9 
1976 3.2 2.9 3.5 
1977 4.3 3.9 4.7 
1978 5.3 4.9 5.7 
1979 5.7 5.3 6.2 
1980 6.7 6.2 7.2 
1981 7.6 7.2 8.1 
1982 8.0 7.5 8.5 
1983 8.0 7.5 8.5 
1984 8.0 7.6 8.5 
1985 8.7 8.2 9.2 
1986 8.6 8.2 9.2 
1987 8.9 8.4 9.4 
1988 9.5 9.0 10.0 
1989 10.4 9.9 10.9 
1990 9.9 9.4 10.4 
1991 10.7 10.1 11.2 
1992 10.8 10.3 11.4 
1993 11.5 10.9 12.0 
1994 11.3 10.8 11.8 
1995 11.8 11.3 12.4 
1996 12.6 12.1 13.2 
1997 12.5 12.0 13.0 
1998 13.4 12.9 14.0 
1999 13.4 12.8 13.9 
2000 13.8 13.3 14.4 
2001 14.2 13.7 14.8 
2002 14.5 13.9 15.0 
2003 14.4 13.9 15.0 
2004 14.1 13.6 14.7 
2005 14.4 13.9 14.9 
2006 13.9 13.4 14.4 
2007 13.9 13.4 14.4 
2008 14.0 13.5 14.6 
2009 13.7 13.2 14.2 
2010 14.0 13.5 14.5 
2011 14.2 13.7 14.7 
2012 13.6 13.2 14.1 
2013 13.9 13.5 14.4 
2014 14.0 13.6 14.5 
2015 13.7 13.3 14.2 
2016 13.2 12.8 13.7 
1975-2016 11.9 11.8 12 
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Table 5: Race based age-adjusted incidence-based mortality rates of endometrial cancer in adult 
(Age >19 Years) women from 1975-2016 
*Other includes American Indian/AK Native, Asian/Pacific Islander 
Year White African American Others* 
 Rate LCI UCI Rate LCI UCI Rate LCI UCI 
1975 1.6  1.4 1.9 2.5 1.4 4.0 0.5 0.1 1.4 
1976 3.0 2.6 3.3 7.1 5.0 9.6 2.6 1.3 4.6 
1977 4.3 3.9 4.7 6.3 4.5 8.6 2.0 1.0 3.6 
1978 5.2 4.8 5.7 6.9 5.2 9.0 2.7 1.5 4.4 
1979 5.8 5.3 6.2 7.0 5.2 9.1 2.4 1.3 4.0 
1980 6.8 6.3 7.3 8.5 6.5 10.9 1.5 0.8 2.7 
1981 7.7 7.2 8.3 9.2 7.1 11.6 3.6 2.2 5.4 
1982 8.0 7.5 8.5 10.7 8.5 13.3 3.8 2.4 5.5 
1983 8.1 7.6 8.6 8.5 6.6 10.6 4.8 3.4 6.7 
1984 8.2 7.7 8.7 9.4 7.4 11.7 3.4 2.2 4.9 
1985 8.8 8.3 9.3 10.7 8.7 13.1 3.8 2.6 5.4 
1986 8.8 8.3 9.3 10.5 8.4 12.8 3.4 2.3 5.0 
1987 9.3 8.8 9.9 8.7 6.9 10.7 2.7 1.7 4.0 
1988 9.8 9.3 10.4 9.8 7.9 12.0 4.3 3.0 5.9 
1989 10.6 10.1 11.2 11.7 9.6 14.0 4.7 3.4 6.4 
1990 10.2 9.7 10.8 10.6 8.6 12.8 4.0 2.9 5.5 
1991 11.1 10.5 11.6 10.7 8.8 12.8 4.3 3.1 5.8 
1992 11.3 10.7 11.8 10.1 8.2 12.1 4.7 3.5 6.2 
1993 11.8 11.2 12.4 12.3 10.3 14.5 5.6 4.2 7.1 
1994 11.6 11.0 12.2 11.6 9.7 13.7 6.2 4.8 7.8 
1995 12.2 11.7 12.8 11.4 9.5 13.5 6.1 4.8 7.7 
1996 13.3 12.7 13.9 11.0 9.1 13.0 6.1 4.8 7.5 
1997 13.0 12.4 13.6 11.9 10.0 14.0 6.4 5.1 7.8 
1998 14.2 13.6 14.8 10.9 9.2 13.0 5.8 4.6 7.2 
1999 14.1 13.5 14.7 11.5 9.7 13.5 5.7 4.5 7.0 
2000 14.5 13.9 15.1 13.6 11.7 15.8 6.4 5.2 7.8 
2001 14.9 14.3 15.6 11.8 10.0 13.8 7.5 6.2 9.0 
2002 15.1 14.5 15.7 13.0 11.1 15.1 7.9 6.6 9.4 
2003 15.0 14.4 15.7 13.4 11.5 15.5 7.8 6.6 9.2 
2004 14.8 14.2 15.4 12.8 11.0 14.8 7.3 6.1 8.6 
2005 15.1 14.5 15.7 12.9 11.1 14.9 7.1 6.0 8.4 
2006 14.6 14.0 15.2 12.8 11.1 14.8 6.9 5.8 8.1 
2007 14.6 14.1 15.2 12.1 10.4 13.9 7.3 6.2 8.6 
2008 14.8 14.2 15.4 13.5 11.7 15.4 6.7 5.7 7.9 
2009 14.3 13.7 14.8 13.2 11.5 15.0 8.1 7.0 9.4 
2010 14.5 14.0 15.1 13.1 11.4 14.9 9.0 7.8 10.3 
2011 14.8 14.2 15.4 14.9 13.1 16.8 8.2 7.1 9.4 
2012 14.3 13.8 14.9 14.2 12.5 16.0 7.2 6.2 8.3 
2013 14.6 14.0 15.1 14.4 12.8 16.3 7.9 6.9 9.0 
2014 14.8 14.2 15.3 14.5 12.9 16.3 7.5 6.5 8.6 
2015 14.3 13.8 14.9 13.9 12.4 15.6 8.5 7.5 9.6 
2016 13.7 13.1 14.2 14.7 13.1 16.5 8.4 7.4 9.5 
1975-2016 12.3 12.2 12.4 12 11.7 12.3 6.6 6.4 6.8 
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Table 6: Overall and race based annual age-adjusted incidence-based mortality rate trends 
(Joinpoint Analysis for 1975-2016)  
Joinpoint Analysis (1975-2016) 
 
Overall/Race AAPC** 
Trend 1 Trend 2 Trend 3 Trend 4 
Years APC* Years APC* Years APC* Years APC* 
Overall 5.1 1975-
1977 
58.9 1977-
1981 
13.7 1981-
2001 
3.3  2001-
2016 
-0.4 
White 5.4 1975-
1977 
63.5 1977-
1981 
14.6 1981-
2001 
3.4 2001-
2016 
-0.4 
African American 2.8 1975-
1981 
12.4 1981-
2016 
1.3 
    
 
Figure 5: Overall age-adjusted incidence-based mortality rate trend of endometrial cancer 
(Joinpoint Analysis for 1975-2016)  
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Figure 6: Age-adjusted incidence-based mortality rate trend of endometrial cancer among adult 
white women (Joinpoint Analysis for 1975-2016)  
 
Figure 7: Age-adjusted incidence-based mortality rate trend of endometrial cancer among adult 
African American women (Joinpoint Analysis for 1975-2016)  
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